| Also known as |
Rabeprazole sodium |
| Blood pressure |
No significant effect |
| Chemical name |
2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
| Dosage (medical) |
Typically 20 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Decreases stomach acid production, aids in healing of acid-related diseases |
| Formula |
C18H21N3O3S |
| Half-life |
Approximately 1 to 2 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
No specific lab test required |
| Main action |
Reduces gastric acid secretion |
| Side effects |
Headache, diarrhea, stomach pain, sore throat |
| Storage conditions |
Store at 20В°C to 25В°C (68В°F to 77В°F) |
| Strength |
20 mg |
| Substance class |
Proton pump inhibitor |
| Trade name |
Aciphex |
| Use in sports |
Not applicable |
| Water Retention |
No |
| Manufacturer |
Pharmaceutical |
